Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6 Diazo 5 Oxo L Norleucine
2. Diazooxonorleucine
1. 157-03-9
2. Diazooxonorleucine
3. L-don
4. L-norleucine, 6-diazo-5-oxo-
5. 6-diazo-5-oxo-l-nor-leucine
6. L-6-diazo-5-oxonorleucine
7. L-norleucine,6-diazo-5-oxo-
8. Don
9. Nsc-7365
10. 03j0h273kz
11. Don (pharmaceutical)
12. Mfcd00037218
13. Nsc 7365
14. Brn 1725815
15. Norleucine,6-diazo-5-oxo-
16. Nsc7365
17. (s)-2-amino-6-diazo-5-oxocaproic Acid
18. Unii-03j0h273kz
19. Ai3-26441
20. Norleucine, 6-diazo-5-oxo, L-
21. Ncimech_000302
22. Ncistruc1_000220
23. Ncistruc2_000175
24. (l)-don
25. 4-04-00-03278 (beilstein Handbook Reference)
26. Chembl97485
27. Chembl4303391
28. Diazo-5-oxo-l-norleucine, 6-
29. Schembl15349013
30. Schembl15349015
31. Kmx-010
32. Nci7365
33. Chebi:138889
34. Dtxsid501028846
35. Ex-a1965
36. Zinc3953825
37. Ccg-35449
38. Ccg-37571
39. Ncgc00013078
40. Akos030213039
41. Ncgc00013078-02
42. Ncgc00096202-01
43. 6-diazo-5-oxo-l-norleucine, Crystalline
44. 6-diazo-5-oxo-l-norleucine [mi]
45. (2s)-2-amino-6-diazo-5-oxohexanoic Acid
46. Hy-108357
47. (2s)-2-amino-6-diazo-5-oxo-hexanoic Acid
48. Cs-0028442
49. A936514
50. Q245487
51. J-009370
| Molecular Weight | 171.15 g/mol |
|---|---|
| Molecular Formula | C6H9N3O3 |
| XLogP3 | -3.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 171.06439116 g/mol |
| Monoisotopic Mass | 171.06439116 g/mol |
| Topological Polar Surface Area | 82.4 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 232 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 1 |
Antimetabolites, Antineoplastic
Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
ABOUT THIS PAGE
A 6 Diazo 5 oxo L norleucine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 6 Diazo 5 oxo L norleucine, including repackagers and relabelers. The FDA regulates 6 Diazo 5 oxo L norleucine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 6 Diazo 5 oxo L norleucine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 6 Diazo 5 oxo L norleucine supplier is an individual or a company that provides 6 Diazo 5 oxo L norleucine active pharmaceutical ingredient (API) or 6 Diazo 5 oxo L norleucine finished formulations upon request. The 6 Diazo 5 oxo L norleucine suppliers may include 6 Diazo 5 oxo L norleucine API manufacturers, exporters, distributors and traders.
6 Diazo 5 oxo L norleucine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 6 Diazo 5 oxo L norleucine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 6 Diazo 5 oxo L norleucine GMP manufacturer or 6 Diazo 5 oxo L norleucine GMP API supplier for your needs.
A 6 Diazo 5 oxo L norleucine CoA (Certificate of Analysis) is a formal document that attests to 6 Diazo 5 oxo L norleucine's compliance with 6 Diazo 5 oxo L norleucine specifications and serves as a tool for batch-level quality control.
6 Diazo 5 oxo L norleucine CoA mostly includes findings from lab analyses of a specific batch. For each 6 Diazo 5 oxo L norleucine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
6 Diazo 5 oxo L norleucine may be tested according to a variety of international standards, such as European Pharmacopoeia (6 Diazo 5 oxo L norleucine EP), 6 Diazo 5 oxo L norleucine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (6 Diazo 5 oxo L norleucine USP).
LOOKING FOR A SUPPLIER?
